INTRODUCTION
Some organisms such as yeast or social insects are haploid, i.e., they carry a single set of chromosomes (Otto and Jarne, 2001) . Haploidy in yeast has been utilized to identify fundamental mechanisms of biology (Hartwell et al., 1974) . However, all somatic mammalian cells carry two copies of chromosomes (i.e. exhibit diploidy) that obscure mutational screens. Organisms with a single copy of their genome, such as yeast, provide a basis for genetic analyses where any recessive mutation of essential genes will show a clear phenotype due to the absence of a second gene copy (Hartwell et al., 1974) . It has been shown recently (Carette et al., 2009 (Carette et al., , 2011a (Carette et al., , 2011b ) that haploid mammalian cells allow forward genetic screens. However, no somatic haploid cell has ever been reported in mammals, likely because haploidy is incompatible with mammalian development (Latham et al., 2002) . To this date, haploidy has been achieved in fish embryonic stem cells (ESCs) (Yi et al., 2009 ) and human KBM-7 leukemia cells (Carette et al., 2009 (Carette et al., , 2011a Kotecki et al., 1999) , and by electrofusion to generate hybrid cells (Yan et al., 2000) .
Here we show that it is possible to generate mammalian haploid ESC lines from parthenogenetic mouse blastocysts derived from activated oocytes. Such cells show stable growth over multiple passages, can be efficiently subcloned, differentiate at similar kinetics as diploid ESCs, and can maintain haploidy even upon initiation of differentiation. Moreover, we provide evidence that haploid ESCs can be readily utilized for reverse genetics and forward genetic screens. Our study provides the experimental framework for a system that carries the promise to combine functional genomics with mammalian stem cell biology.
RESULTS

Derivation of Haploid Cell Lines from Parthenogenetic Murine Blastocysts
Parthenogenetic embryos develop from haploid oocytes and thus contain only the maternal genome. However, all reported cell lines derived from parthenogenetic embryos carry a diploid set of chromosomes (Kaufman et al., 1983) . We hypothesized that haploid cells might still be present in parthenogenetic early embryos and that haploid ESCs could be derived from such blastocysts. To accomplish this, we activated oocytes from superovulated C57BL/6 3 129 F1 females by exposing them to 5% ethanol. Activated oocytes were then transferred into pseudopregnant recipients ( Figure 1A ). At embryonic day (ED) 3.5, compacted morulae and blastocysts were harvested and cultivated under conditions used to derive ESCs. FACS analysis showed that a small number of the parthenogenetically derived cells indeed displayed a reduced DNA content ( Figure S1A available online). Several rounds of FACS purification of this population and subsequent expansion resulted in two independent cell lines derived from two distinct blastocysts, hereafter termed HMSc1 and HMSc2, with a 1n chromosome set in the G1 phase and a 2n chromosome set in the G2 phase of the cell cycle (Figure 1B,  Figure S1A ). Chromosome spreads showed that both cell lines carry a haploid set of 20 chromosomes (Figure 1C, Figure S1B) . Of note, both cell lines have now been passaged >50 times without any signs of proliferative crisis. Thus, exploiting activation of meiotic oocytes and parthenogenetic derivation of blastocysts has allowed us to establish mouse cells with a haploid chromosome set.
Genome Integrity
To genetically characterize our haploid cells, we compared their genomes to the genomes of the parental in-house mouse strains C57BL/6 and 129 using deep sequencing and performed (D and E) Sequence coverage relative to the common reference of parental in-house C57BL/6 and 129 strains is shown on a log2 scale. Haploid cells were derived from C57BL/6 3 129 crosses. Chromosomes are arranged in numerical order and separated by small gaps. See also Figure S1 .
a discriminative coverage analysis. Briefly, we assessed the counts of sequencing reads, not counting duplicates that map to unique genomic positions, in a sliding window of 50 kb (10 kb offset), normalized to the total number of reads that mapped to the genome in each library. As expected, we found that the strains differed at many positions. We therefore compared deep sequencing reads from genomic DNA of both our haploid cell lines to both parental strains individually and in a combined fashion in which we focused on deviations with respect to both parental strain ( Figures 1D and 1E ). In total, we found that HMSc1 differed from the parental strains by more than 2-fold (multiple-testing corrected p % 10 À3 ) in 1,553 overlapping windows corresponding to 219 nonoverlapping regions; HMSc2 had 568 windows (113 regions) with increased read-counts and 61 windows (10 regions) with decreased read-counts (R2-fold; multiple-testing corrected p % 10 À3 ; Table S1 available online).
Of note, 1,155 windows with increased read-counts and 99 windows with decreased read-counts overlapped between HMSc1 and HMSc2, while only 397 and 4 were distinct, respectively. We do not know the origin of this observation, but these shared copy number variations (CNVs) might stem from biases of the sequencing procedure during DNA preparation from different cell types (ESCs versus adult kidney), or they might constitute a batch effect during sequencing. Thus, taken together, our haploid cell lines display a limited number of defined CNVs compared with the parent strains, suggesting that they likely harbor small duplications and deletions, data similar to those of previous reports using established ESC (Baker et al., 2007) or iPSC (Hussein et al., 2011) lines. To confirm that both haploid cell lines are indeed distinct given the similarity in copy number analysis, we made use of the fact that they were derived from oocytes of C57BL/6 3 129 intercrosses, in that meiotic recombination should result in distinct haplotype structures. We compared the deep sequencing reads to small nucleotide polymorphisms (SNPs) obtained from the Sanger Institute release that differed between both mouse strains. Our sequences covered 1.5 million (HMSc2) and 1.7 million (HMSc1) distinct SNPs and allowed a unique assignment of the corresponding genomic regions to one of both parents.
Comparing the SNPs present in HMSc1 and HMSc2 cells indeed confirmed that we had derived two independent haploid clones ( Figure S1C ). In summary, the CNV analysis together with FACS and chromosome spreads show that both cell lines are derived independently and exclude the possiblity that HMSc1 and HMSc2 have substantial parts of the genome or individual chromosomes deleted or duplicated.
Expression of Prototypic ESC Markers
We next tested whether our haploid cell lines express prototypic ESC markers, i.e., whether our haploid cells are indeed ESCs. Both parthenogenetically derived haploid HMSc1 and HMSc2 lines exhibited typical morphologies of ESCs and stained positive for the ESC marker alkaline phosphatase (Figure 2A ). Immunolabeling to detect Oct4, Nanog, and Sox2 ( Figure 2B ) confirmed that HMSc1 and HMSc2 cells express prototypic ESC markers. Transcriptome analysis showed that the expression profile for both haploid cell lines closely resembled that of the diploid ESC line IB10/C ( Figure S2A ). To focus on genes with the highest discriminatory value, we analyzed a set of 100 genes for maximum difference in gene expression in either direction between mouse embryonic fibroblasts (MEFs) and diploid ESCs, among them Nanog, Oct4, and Klf4 (Chambers et al., 2003) . Analysis of this gene set showed that both HMSc1 and HMSc2 cell lines exhibit an expression signature that closely resembles that of the bona fide diploid ESC line IB10/C (Figure S2B , Table S2 ). qPCR analyses confirmed that both HMSc1 and HMSc2 cells express prototypic ESC markers (Figure 2C) (Elling et al., 2006; Takahashi and Yamanaka, 2006) . Taken together, global transcriptome profiling and expression analysis of prototypic stem cell markers confirmed the ESC nature of both haploid cell lines.
Differentiation Potential of Haploid ESCs In Vitro
To test the differentiation potential of our haploid ESCs, we first assayed for embryoid body (EB) formation. Both haploid cell lines readily underwent EB formation and EB cells expressed the endodermal marker (Soudais et al., 1995) Gata4 ( Figure 2D ). Differentiation was further confirmed using real time PCR. The prototypic ESC markers Nanog, Rex1, Oct4, Sox2, Klf4, Sall4, and Kfl2 (Chambers et al., 2003; Robertson et al., 1986; Takahashi and Yamanaka, 2006) were downregulated in EBs while mRNA expression of the lineage commitment markers (Zhang et al., 2010) Hand1 (mesoderm and trophectoderm), Nkx2-5 and Brachyury (mesoderm), Nestin (neural), Gata4, Gata6, and Foxa2 (all early endoderm), Sox17 (endoderm and mesoderm), Cxcr4R (endoderm), and Keratin18 (ectoderm) was upregulated relative to those of the parental haploid ESCs ( Figure 2E, Figure S2C) . These results indicate that the haploid ESCs are capable of differentiation into several lineages of all three germ layers.
In Vivo Differentiation Potential
To evaluate the ability of the established haploid ESC lines to contribute to adult mice, we injected cells from the Agouti + ESC line HMSc2 into ED 3.5 blastocysts. To assure competitive growth and thus efficient contribution, diploid cells derived from haploid HMSc2 were used. Coat color chimerism was observed in 6 animals out of 25 mice born ( Figure 3A ). To analyze contribution of the entirely maternal-derived cells to various organs as previously reported for parthenogenotes (Thomson and Solter, 1988) , we performed a distinguishing PCR and detected HMSc2-derived cells in multiple tissues ( Figure S3A ). To test the intrinsic differentiation potential of our haploid ESCs, we performed in vivo teratoma assays. Similar to diploid ESC controls, injection of both HMSc1 and HMSc2 cells always resulted in the formation of teratomas within 4-8 weeks.
In teratomas derived from both haploid ESC lines, we observed mesoderm-derived muscle cells, endoderm-derived Alcian-blue + epithelial tissues that produce mucin, neuroectoderm-derived Tuj1 + neurons, and ectoderm-derived Cytokeratin 5 + epithelial tissues ( Figure 3B ). In addition, we observed bona fide cartilage tissue, fat, keratinized multilayered epithelium, pigmented epithelium, sebaceous sweat glands, glandular and neuronal tubules, and ciliated respiratory epithelium . These data show that haploid ESC-derived cells have the potential to contribute to chimeric mice and that they can differentiate in vivo into cells of all three germ layers.
The Ability of Stable Growth and Differentiation Is Intrinsic to Haploid ESCs
To assess whether our haploid ESCs have the intrinsic ability for stable growth, we established several individual cell clones by plating single haploid cells directly after FACS purification. These subclones were established in feeder-free conditions and were derived from both HMSc1 and HMSc2 parental lines that were previously cultured for more than 30 passages. All derived subclones expressed the stem cell markers Oct4 and Sox2 (Figure 4A, Figure S4 ) and formed EBs that contained Gata4 + endodermal cells and Tuj1 + neurons ( Figure 4A , Figure S5 ). The haploid subclone HMSc2-27 was chosen for further studies based on its growth rates and numbers of stable haploid cells (Figures S6A and S6B) . Typical stem cell morphologies, protein expression of Oct4, Nanog, and Sox2, and a haploid set of chromosomes were confirmed for the HMSc2-27 subclone ( Figures S6C-S6F ). The growth rates of HMSc2-27 cells at different haploid:diploid (B) Expression of Oct4, Nanog, and Sox2, prototypical markers for murine ESCs. Phalloidin staining indicates the feeder cell layer. Haploid HMSc1 and HMSc2 cells were costained for Oct4 (FITC) and Nanog (TRITC). In both cases, stainings are shown separately in the red channel. Scale bars are 50 mm. Data are from cells after the fourth sort. (C) Expression of prototypic ESC marker genes in the haploid HMSc1 (blue) and HMSc2 (red) cells. mRNA expression was determined using qPCR and normalized to diploid IB10/C ESCs (black bars). Mean and SD of three biological replicates (each done in triplicates) is shown. (D) Gata4 protein expression in embryoid bodies (EB, day 7) as a marker for endoderm. Representative EBs are shown for both haploid HMSc1 and HMSc2 ESC lines counterstained with phalloidin (green). Scale bars are 50 mm. (E) qPCR revealed downregulation of the ESC markers Nanog, Rex1, Oct4, Sox2, Klf2, Klf4, and Sall4 in EBs (day 7) derived from the haploid ESC line HMSc2 accompanied by expression of the indicated lineage commitment markers (see text). mRNA expression was normalized to the parental, undifferentiated haploid ESCs (set at 1). Mean and SD of three biological replicates (each done in triplicates) is shown. See also Figure S2 . seeding ratios were comparable to those of purely diploid HMSc2-27 cells ( Figure 4B ). Of note, these growth rates are comparable to those of previously established ESC lines. Kinetic studies on diploid versus haploid cell ratios in cultures of HMSc2-27 cells showed that a large fraction of these cells maintains haploidy for a period of seven passages ( Figure 4C ). Differentiation of HMSc2-27 ESCs into EBs followed by lineagespecific differentiation protocols showed that these cells have the capability to form Gata4 + endoderm, Tuj1 + neuronal lineage ( Figure 4A ), and mesodermal ''beating'' myoblasts ( Figure 4D ; for synchronous contractions see Movie S1 and Movie S2). Moreover, in in vivo teratoma assays HMSc2-27 cells can differentiate into cells of all germ layers (not shown). To confirm the subcloning experiment, i.e., to make sure that cloning from a single haploid ESC indeed works, we generated GFP + subclones. All cells from the established subclones expressed GFP, irrespective of whether they were at a stage of haploidy or diploidy (Figure 4E) . Because diploid cells cannot become haploid, these experiments confirm that all cells of such clones must have been derived from a single haploid cell. The HMSc2-27 subclone allowed us to examine the differentiation potential of these cells at a haploid versus diploid state. Haploid HMSc2-27 ESCs were indeed able to downregulate Oct4 and form Tuj1 + neurons and Gata4 + endodermal cells in EB cultures ( Figure 4F ). We next attempted to differentiate haploid HMSc27 cells directly (without formation of EBs) into neural and astrocyte lineages (Pollard et al., 2006 However, when such neural progenitors were further differentiated toward astrocytes and neurons, all Nestin + cells became diploid within 4 days ( Figure 5B ). The differentiation capacity of haploid cells was further assessed using high content screening analysis of Oct4 expression (Walker et al., 2007 (Walker et al., , 2010 , DAPI intensity, and nuclear area, enabling automated determination of the differentiation state of haploid and diploid HMSc2-27 cells ( Figure S7 ). ESCs cultured in presence of LIF for 72 hr maintained high levels of Oct4 as depicted by mean Oct4 expression intensity ( Figure 5C , left panel). Distribution analysis showed that HMSc2-27 cells that became diploid expressed a slightly higher level of Oct4 than haploid cells, consistent with the larger nucleus. Upon LIF withdrawal, Oct4 expression substantially decreased in haploid and diploid HMSc2-27 cells ( Figure 5C , middle panel). Moreover, differentiation in response to 0.5 mM retinoic acid dramatically reduced Oct4 expression in haploid and diploid HMSc2-27 cells to that of background levels ( Figure 5C , right panel), similar to results obtained using 0.1 mM retinoic acid (data not shown), indicating efficient differentiation. These data show that haploid ESCs can differentiate at kinetics similar to those of diploid ESCs and, importantly, that haploid stem cells can maintain haploidy even upon initiation of differentiation.
Retroviral Mutagenesis
The idea behind establishing haploid ESCs was to create a tool for forward and reverse genetics at the genomic scale. To demonstrate the power of mutagenesis in haploid mouse ESCs, we infected 5 3 10 8 cells of a freshly FACS-purified haploid culture of HMSc2-27 with a previously reported retrovirus containing a reversible gene trap (Schnü tgen et al., 2008) . This vector also contains removable Oct4 binding sites (Schnü tgen et al., 2008) , which allow insertions into genes that show minimal or no detectable expression in stem cells. After infection, 7.5 3 10 6 independent genomic insertions were generated as estimated from colony formation assays. ESC colonies were then pooled and 10 mg of genomic DNA corresponding to 3 million cells was analyzed to map the viral insertion sites by inverse PCR and deep sequencing. We could unambiguously identify 176,178 insertions. About half of the insertions were mapped to intergenic regions and $51% of insertions occurred in promoter regions and intragenic regions encompassing 8,203 different genes (5 0 and 3 0 UTR, first intronic, other intronic, and coding regions) ( Figure 6A ). Among the intragenic insertions, approximately half (53%) were in the sense direction, and half were in the antisense direction. Of note, we observed frequent insertions into the first intron, which most likely will result in complete disruption of gene expression/function. To analyze gene trap efficacy, we divided genes into 10 bins based on their expression levels in HMSc2 cells (0%-10% equals lowest expression, and 90%-100% equals the most highly expressed genes). As expected, more highly expressed genes were more often hit (up to 67%). Importantly, due to the engineered Oct4 binding sites (Schnü tgen et al., 2008) , we were able to obtain frequent (31%) insertions into genes that show minimal or no detectable expression in ESCs ( Figure 6B ). We next analyzed the numbers of genes that are trapped by all 176,178 insertions or fractions of the total insertions ( Figure 6B ; all insertions are set to 100% at the x axis). This analysis shows that mutagenesis has not reached saturation, indicating that higher numbers of insertions will increase the numbers of targeted genes. Considering that our library consists of 403 more (7.5 3 10 6 ) independent integrations, our mutagenesis protocol has, in principle, the power to disrupt most genes.
Haploid Murine ESCs as a Tool for High-Throughput Reverse Genetics
Using our retroviral mutagenesis set-up, we next picked individual clones, identified the insertion sites of about 1,000 cell lines (not shown), and selected 10 clones with sense or antisense insertions for further analysis. PCR analysis with site-specific primers confirmed that our sequencing approach identified the correct target sites in all 10 cases ( Figure 6C ). Most importantly (E) GFP expression (green) in a GFP-tagged haploid ESC subclone. Non-GFP labeled cells are shown as control (gray shaded histogram). Flow cytometry of DNA content (Hoechst33342) is shown for the same subclone demonstrating that both haploid and diploid cells express GFP. (F) Differentiation of haploid and diploid HMSc2-27 cells into EBs (day 13) that contain Tuj1 neurons (green) and Gata4-expressing endodermal cells (red . Differentiation induction using 0.5 mM retinoic acid results in a rapid loss of Oct4 expression in both haploid and diploid cells, indicative of differentiation (right panel). The same results were obtained when we used 0.1 mM retinoic acid (not shown). Data are shown as mean Oct4 fluorescence intensity ± SEM analyzing more than 50,000 cells per condition. One-way ANOVA (p > 0.05) showed increased expression of Oct4 in diploid cells (consistent with increased nuclear area) in all conditions except the 48 hr and 72 hr retinoic acid treatments wherein Oct4 expression was at background levels. See also Figure S7 . these data also show that all 10 clones carry homozygous insertions ( Figure 6D ), indicating that mutagenesis has occurred in haploid cells and that this approach is indeed feasible for recessive genetics.
Two clones carrying insertions in the genes encoding the retinoic acid receptor gamma (Rarg) and Drosha were functionally validated using parental wild-type (WT) HMSc2-27 cells, or ESCs clones that carry the retroviral vector in antisense orientation. By transient Cre expression we then converted the alleles to sense integrations in which the splice acceptor disrupts gene expression; this approach allows immediate confirmation of the candidate gene and excludes potential background 
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Derivation of Murine Haploid Embryonic Stem Cells mutations. Indeed, sense, but not antisense, integrations of the splice acceptor results in a near complete absence of Rarg mRNA expression ( Figure 6E ). Functionally, whereas ESCs carrying the WT allele or the splice acceptors in antisense orientation undergo rapid differentiation and cell death upon retinoic acid treatment, disruption of Rarg expression renders ESCs insensitive to such retinoic acid effect ( Figure 6F ). The RNase III Drosha catalyzes the conversion of pri-miRNA transcripts into pre-miRNA stem-loop precursors in the nucleus . Due to this pivotal role in the initial step of miRNA processing, homozygous Drosha inactivation is predicted to severely impair miRNA biogenesis. While a conditional Drosha knockout mouse has been published previously (Chong et al., 2008) , no viable Drosha knockout cell line has been reported yet. We were indeed able to generate a Drosha mutant ESC clone following Cre-mediated inversion of the splice acceptor ( Figure 6G ). As reported for ESCs with mutations in the pasha ortholog Dgcr8 (Wang et al., 2007) , which together with Drosha is part of a protein complex called the Microprocessor complex (Denli et al., 2004) , Drosha mutant ESCs cannot form cystic EBs ( Figure 6H ). To evaluate primary miRNA processing in ESCs harboring the disrupted Drosha allele, we monitored the effects of a potent miR30-based shRNA (shmiR.Luc1309) on expression of a transcript harboring a Luc1309-specific shRNA target site (target) in the 3 0 UTR of a sequence encoding the Venus reporter protein (Fellmann et al., 2011) . While expression of shmiR.Luc1309 strongly suppressed Venus expression in normal ESCs, our Drosha-deficient ESC clone did not show shRNA-mediated reporter suppression ( Figure 6I ), indicating a dysfunctional miRNA pathway. These data show that haploid ESCs can be indeed efficiently used for reverse genetics creating reversible and homozygous mutations.
A Genome-Wide Screen for Genes Involved in Ricin Toxicity Finally, we set out to perform a recessive forward genetic screen at the genome level using our haploid ESC system. The naturally occurring ricin toxin from the castor oil plant Ricinus communis is highly poisonous. At the molecular level, ricin binds to N-acetyl galactosamine or beta-1,4-linked galactose residues and mannose receptors on the cell surface, and ricin molecules are thought to follow retrograde transport via the Golgi apparatus to enter the lumen of the endoplasmic reticulum (ER), where they escape into the cytosol to inactivate ribosomes (Spooner and Lord, 2011 ). Because we found that ricin is highly toxic to mouse ESCs, we used our mutagenized haploid HMSc2-27 cell library and challenged the cells with a lethal dose of ricin. Whereas ricin killed all control ESCs, we observed growth of multiple ESC colonies from the mutagenized haploid HMSc2-27 cells ( Figure 7A) . These clones were then pooled and deep sequenced so we could determine the integration sites. As expected from previous studies, we found multiple enzymes involved in sugar metabolism: beta-1,4-galactosyltransferase 1 (B4galt1), , polypeptide N-acetylgalactosaminyltransferase2 (Galnt2), glycoprotein galactosyltransferase alpha 1,3 (Ggta1), and polypeptide N-acetylgalactosaminyltransferase3 (B4galnt3) (Figures 7B and 7C) . We also obtained multiple disruptive mutations in the alpha-(1,3)-fucosyltransferase Fut9, and we hit the GDP-fucose transporter1 Slc35c1 ( Figure 7B and 7C) . The fucosylation pathway has until now never been associated with ricin toxicity. Intriguingly, we observed 49 different integrations in the GPCR Gpr107 (LUSTR1) (Figure 7B ), suggesting that Gpr107 is a key molecule involved in ricin toxicity. Knockdown of Gpr107 expression in HMSc2-27 cells using shRNA technology in HMSc2 confirmed the central role of this GPCR in ricin toxicity. The key role of Gpr107 in ricin-induced cell death was further confirmed in a different cell type, NIH 3T3 cells (Figures 7D and 7E ). Of note, our shRNA data are shown as ratios of viable cells recovered from the plates with ricin treatment to those without ricin treatment (% survival): around 1% of nontransduced or control shRNA-transduced cells remained still viable after 48 hr of ricin treatment, as compared with their respective nontreated cells; shRNA-mediated knockdown of Gpr107 significantly enhanced survival of ricin-exposed HMSc2-27 and NIH 3T3 cells, but did not fully protect these cells from ricin toxicity. By contrast, genetic ablation of Gpr107 in haploid HMSc2-27 ESCs as performed for the screen resulted in cells that survived ricin application for 3 weeks and were able to expand and form colonies starting from single, mutated cells. Thus, forward genetic screens are feasible and efficient in our haploid ESCs.
DISCUSSION
Our data show that it is possible to generate mammalian haploid ESC lines from parthenogenetic mouse blastocysts derived from ethanol-activated oocytes. In addition, we have now also successfully used strontium chloride to activate oocytes and derive a third independent haploid ESC line (not shown). Detailed molecular characterization of our haploid ESCs shows that these cells express all classical markers of diploid ESCs, carry 20 chromosomes, and largely maintain genome integrity. Functionally, these haploid ESCs can differentiate into cells from all three germ layers in vitro and in vivo. Although our lines and subclones are stable and in some cases have been maintained for over 70 passages, some haploid cells become diploid. Our mutagenesis data suggest that these cells do not become diploid via cell fusion, but rather via failed cytokinesis and/or endoreplication of the genome. The exact mechanism needs to be determined. Moreover, it will be interesting to determine at what stage of development haploid cells have to become diploid to form a certain cell type, experiments that will be feasible using our high-throughput imaging platform that also allows to us to track haploidy in a single cell.
Most importantly, our haploid ESCs can be mutated and, in all cases we have analyzed to date, these mutations are homozygous, indicating that such haploid cells can be used to analyze recessive and disease phenotypes in various cell lineages in vitro. Although we detected contributions of our cell lines to multiple tissues in vivo, it needs to be determined whether these haploid cells might be able to contribute to the germline. However, germline transmission could be attempted using semicloning techniques as previously reported for Medaka (Yi et al., 2009) .
Our results open the possibility of combining the power of a haploid genome with pluripotency of ESCs. Recessive genetic screens have elucidated a wide variety of biological processes over the last century and thus markedly contributed to our understanding of normal development, basic physiology, and disease (Nü sslein-Volhard and Wieschaus, 1980). However, due to the asexual proliferation cycle, saturated genetic screens in mammals have not been possible in cell culture systems or feasible in vivo (Carette et al., 2009) . RNAi-based approaches have therefore revolutionized functional genomics. However, in many cases RNAi-mediated gene silencing still suffers from variable knockdown, off-target effects, and transient silencing effects (Brummelkamp et al., 2002; Carpenter and Sabatini, 2004; Fellmann et al., 2011) . Recently, genome-wide saturating genetic screens have been introduced to a human leukemia cell line with a near haploid chromosome set (Carette et al., 2009 ) and have been highly successful in, for example, elucidating host factors of toxins or viruses (e.g., Carette et al., 2011b) .
Our experiments based on millions of different integrations generated in a single round of retroviral infection of haploid ESCs show that it should be possible to perform saturated genetic recessive screens in mammalian ESCs and the many cell types that can be derived from them. We also report that reverse genetics is feasible using a vector system that provides immediate confirmation of gene function in the same clones using Cre-mediated conversion of the splice acceptor sites. Using this system we have indeed been able to functionally validate our approach using clones with conditional Rarg and Drosha mutations. Moreover, we performed a forward genetic screen for ricin toxicity, one of the most dangerous poisons Note that nearly all insertions are in sense for the splice acceptor and that some antisense integrations map to exons, all of which should result in disruptive mutations. Considering that $50% of intragenic insertions are sense and $50% are antisense, these data also show that the screen has indeed strongly enriched for disruptive mutations (p > 1. 
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Derivation of Murine Haploid Embryonic Stem Cells also being used/investigated as a biological weapon by governments. Ricin also gained notoriety for its potential use as toxin in bioterrorism (Papaloucas et al., 2008) . This screen in haploid ESCs identified the GPCR Gpr107 as an essential molecule required for ricin-induced killing. Since no antitoxins are available for treatment of ricin poisoning, molecular inhibition of Gpr107 (and possibly other molecules identified by our screen) might be useful to alleviate ricin toxicity in vivo, a hypothesis that now needs to be tested. We anticipate that our haploid ESCs can bridge the power of haploid organisms such as yeast with rapid and whole-genome genetic forward screens in stem cells or any differentiated cell type that one can derive from our haploid mouse ESC lines.
EXPERIMENTAL PROCEDURES Parthenogenetic Activation of Oozytes
Oocytes were collected and incubated in 5% ethanol for 5 min. Subsequently, viable oocytes were transferred into pseudopregnant mice and blastocysts were collected at ED 3.5.
Derivation of ESCs
Blastocysts were placed on a feeder-coated cell culture dish with ESC derivation medium as previously described (Bryja et al., 2006) . Blastocyst outgrowths were trypsinized and replated on a feeder layer to allow ESC colony outgrowth.
Genomic Sequencing
Purified DNA from mouse kidney or ESCs was sheared by sonication and subjected to the Illumina adaptor ligation protocol and sequenced in Illumina HiSeq. Reads were mapped to the genome using bowtie.
Stem Cell Characterization
Cells were analyzed for the presence of stem cell markers using qPCR or immunofluorescent labeling and an enzymatic assay for alkaline phosphatase.
Differentiation
Cells were differentiated by withdrawal of LIF and EB formation or by direct neuronal differentiation (Pollard et al., 2006) . For teratoma formation, cells were injected testicularly or subcutaneously into nude mice and teratoma growth was monitored. To generate chimeric mice, HMSc2 ESCs were injected into C57BL/6 ED 3.5 blastocysts, and transferred into pseudopregnant females. Percentage chimerism was determined by coat color.
Retroviral Infection of ESCs and Inverse PCR
Virus was packaged in Platinum E cells. Selection for gene trap insertions was done using G418. The protocol for inverse PCR was adapted based on Carette et al. (2011a) .
Ricin Toxicity Screen
A mutated library of cells was exposed to a lethal dose of ricin for 3 weeks. DNA of surviving cells was purified, subjected to inverse PCR, and analyzed by deep sequencing. For confirmation using shRNA knockdowns, cells were exposed to ricin for 48 hr and survival was quantified using FACS.
ACCESSION NUMBERS
The microarray data have been deposited in ArrayExpress with accession number E-MEXP-3294. All the primary sequencing data are available from GEO with the accession number SRA047251 for CNV analysis and GSE33184 for retroviral integration site analysis. Furthermore, primary and processed data is accessible at http://www.starklab.org/data/elling_CSC_2011/ and formatted for uploading to the UCSC genome browser (http://genome. ucsc.edu/). Procedures, Figures S1-S7, Tables S1 and S2 , and Movies S1 and S2 and can be found with this article online at doi:10.1016/j.stem.2011.10.012.
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